Advertisement GeneNews makes senior management changes - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

GeneNews makes senior management changes

GeneNews, a Canadian functional genomics company, has announced that Colin West has retired from the position of CFO, vice president of finance and treasurer of the company.

The board of directors has appointed Sonny Young to the role of vice president of finance and treasurer, effective January 1, 2009. Mr West will remain with the company until March 31, 2009, to assist in the transition.

Mr Young is the former director of corporate compliance for OccuLogix. Prior to his role at OccuLogix, he was the controller at Sanofi-Synthelabo and the director of financial accounting at TLC Vision.

The company has also appointed Gino Ariano to the newly created role of senior director, sentry business unit. Mr Ariano is responsible for the sales and marketing of ColonSentry throughout Canada.

Mr Ariano was at Medtronic Canada for more than 10 years, most recently as a national sales manager and, prior to that, government relations and reimbursement manager. Prior to his tenure at Medtronic, he spent nine years with Glaxo Canada (now GSK) with responsibility for a number of pharmaceutical products.

Heiner Dreismann, lead director and interim CEO of GeneNews, said: “Colin has been a valued member of the management team for the past two years. We thank him and wish him well in his retirement. Sonny has been working with GeneNews since April 2006 as a financial consultant. His breadth of experience in financial management makes him well-suited to take on the role of vice president of finance and treasurer.”